Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04146116 · ClinicalTrials.gov registry record · Phase 4
Nasal Decolonization for Orthopedic Trauma Patients
A Phase 4 study, sponsored by University of Iowa.
- Completed
- Registry status
- Phase 4
- Development phase
- 65
- Enrollment target
NCT04146116 is a Phase 4 study that has completed, run by University of Iowa. The registered enrollment target is 65 participants.
The verdict
NCT04146116, a Phase 4 study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 65 participants
- Enrollment target
Study Summary
Many surgical site infections are caused by bacteria that is transferred from a patient's nose to their open surgical wound. Some small studies have shown that putting povidone-iodine in a patient's nose reduces this risk. This study aims to evaluate the real-world effectiveness of nasal povidone-iodine (PROFEND®) in a group of 50 patients at the University of Iowa.
Interventions
- DRUG intranasal povidone-iodine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2021-06-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04146116
The ClinicalTrials.gov registry entry for NCT04146116 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intranasal povidone-iodine is the first listed.
NCT04146116 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04146116 about?
NCT04146116 is a clinical study titled "Nasal Decolonization for Orthopedic Trauma Patients". Many surgical site infections are caused by bacteria that is transferred from a patient's nose to their open surgical wound. Some small studies have shown that putting povidone-iodine in a patient's nose reduces this risk. This study aims to evaluate the real-world effectiveness of nasal povidone-io...
What is the current status of trial NCT04146116?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 65 participants. The study started on 2020-02-19. Estimated completion is 2021-06-08.
What interventions are being tested in trial NCT04146116?
The interventions under investigation include: intranasal povidone-iodine (DRUG).
Who is sponsoring clinical trial NCT04146116?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.